Catalyst Wire Dossier Catalyst Wire Dossier

AFX2 Endovascular System

· Endologix, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AFX2 Endovascular System, covering 2025-05-25 to 2025-05-25. Get the full timeline:

Most recent: Clinical Trial Update: The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System

See pricing